The meta-analysis conducted by Chang et al. [21] confirmed that p53 expression was more prevalent in malignant GIST and associated with high-risk classification, thereby reinforcing its prospective role in malignancy risk stratification. This evidence concerns the gene TP53 and gastrointestinal stromal tumor.